Microbiome gut community structure and functionality are associated with symptom severity in non-responsive celiac disease patients undergoing a gluten-free diet
mSystems · 2025
DOI: 10.1128/msystems.00143-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift mSystems, 2025. Verfasst von Laura Judith Marcos-Zambrano und 10 weiteren Autor:innen. Beteiligte Einrichtung: Computational Biology Group, IMDEA Food, CEI UAM+CSIC, Madrid, Spain. Hauptthemen laut MEDLINE: Celiac Disease, Diet, Gluten-Free, Gastrointestinal Microbiome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Comunidad de Madrid.
Abstract (Originalsprache)
Non-responsive celiac disease (NRCD) challenges clinicians due to persistent symptoms despite a gluten-free diet (GFD). We present a cross-sectional pilot study including 39 NRCD patients to describe the underlying mechanisms contributing to symptom persistence by integrating different levels of data (fecal shotgun metagenomics, mucosal integrity markers, and metabolomic profiles) and using microbial networks to unravel the community structure of the patient’s microbiome. Two distinct clusters of patients were identified based on clinical and demographic variables not influenced by gluten consumption. Cluster 1, labeled “Low-grade symptoms,” displayed milder symptoms and lower inflammatory markers and a fragmented microbial network characterized by high modularity and a reliance on localized hubs, suggesting a microbial community under stress but capable of maintaining limited functionality. Cluster 2, named “High-grade symptoms,” exhibited more severe symptoms, elevated inflammatory markers, and a more connected but antagonistic microbial network with a greater number of keystone taxa, including taxa associated with Th17 activation and inflammation. In contrast, the control network, representing asymptomatic treated celiac disease (tCD) patients, was highly interconnected, resilient, and cooperative, with a robust structure maintained even under simulated disruptions. Metabolomic analysis revealed differential metabolites between clusters, particularly those involved in amino acid metabolism pathways and microbial-derived metabolites such as indolelactic acid and mannitol, which were associated with symptom severity. This study identifies NRCD subgroups based on the gut microbiome and metabolic signatures associated with clinical manifestations, highlighting variations in microbial network stability and metabolite profiles as contributors to symptom persistence and potential therapeutic targets. IMPORTANCE Celiac disease (CD) is a chronic immune-mediated systemic disorder caused by consuming gluten in genetically susceptible individuals. There is currently no cure for CD, and the most effective treatment is maintaining a strict, lifelong gluten-free diet (GFD). This nutritional therapy aims to prevent the immune reaction triggered by gluten and promote the healing of the intestinal lining, resolving the clinical, serological, and histological abnormalities within 6–12 months. However, up to 30% of patients may continue to experience symptoms or exhibit laboratory abnormalities or intestinal inflammation suggestive of active CD, despite following a GFD. This challenge, which encompasses various diagnoses, is known as nonresponsive celiac disease (NRCD). In this study, we explored the role of intestinal microbiota in causing NRCD, finding an association between the persistence of symptoms and changes in mucosal integrity biomarkers, with different gut microbiome structures among NRCD patients, indicating a significant role of the microbiome in NRCD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Computational Biology Group, IMDEA Food, CEI UAM+CSIC, Madrid, Spain.
- UAM Doctoral School, Universidad Autónoma de Madrid, Madrid, Spain.
- GENYAL Platform, IMDEA Food, CEI UAM+CSIC, Madrid, Spain.
- Department of Pharmacy and Nutrition, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Villaviciosa de Odón, Spain.
- Foodomics Lab, Institute of Food Science Research (CIAL, CSIC), Madrid, Spain.
- Department of Nutrition and Food Science, Faculty of Pharmacy, VALORNUT Research Group, Complutense University of Madrid, Madrid, Spain.
ORCID-Profile: Laura Judith Marcos-Zambrano
Förderung
- Comunidad de Madrid
Zitieren
APA
Marcos-Zambrano, L. J., Lacruz-Pleguezuelos, B., Aguilar-Aguilar, E., Marcos-Pasero, H., Valdés, A., Loria-Kohen, V., Cifuentes, A., Ramirez de Molina, A., Diaz-Ruiz, A., Pancaldi, V., & Carrillo de Santa Pau, E. (2025). Microbiome gut community structure and functionality are associated with symptom severity in non-responsive celiac disease patients undergoing a gluten-free diet. mSystems. https://doi.org/10.1128/msystems.00143-25
Vancouver
Marcos-Zambrano LJ, Lacruz-Pleguezuelos B, Aguilar-Aguilar E, Marcos-Pasero H, Valdés A, Loria-Kohen V, et al. Microbiome gut community structure and functionality are associated with symptom severity in non-responsive celiac disease patients undergoing a gluten-free diet. mSystems. 2025. doi:10.1128/msystems.00143-25
BibTeX
@article{MarcosZambrano2025,
author = {Marcos-Zambrano, Laura Judith and Lacruz-Pleguezuelos, Blanca and Aguilar-Aguilar, Elena and Marcos-Pasero, Helena and Valdés, Alberto and Loria-Kohen, Viviana and Cifuentes, Alejandro and Ramirez de Molina, Ana and Diaz-Ruiz, Alberto and Pancaldi, Vera and Carrillo de Santa Pau, Enrique},
title = {Microbiome gut community structure and functionality are associated with symptom severity in non-responsive celiac disease patients undergoing a gluten-free diet},
journal = {mSystems},
year = {2025},
doi = {10.1128/msystems.00143-25}
}
EUVIMED